Dalbavancin 00480-3325
Product NDC
00480-3325- Manufacturer
- Teva Pharmaceuticals, Inc.
- Dosage Form
- Injection, Powder, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 29, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA219465
Need to source Dalbavancin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dalbavancin Hydrochloride | 500 mg/25mL |
Drug Class
Lipoglycopeptide Antibacterial [EPC]Lipoglycopeptides [CS]
Packaging Options(1)
1 VIAL in 1 CARTON (0480-3325-01) / 25 mL in 1 VIAL